TIAA CREF INVESTMENT MANAGEMENT LLC - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$2,224,000
-13.2%
172,687
+2.4%
0.00%0.0%
Q4 2018$2,562,000
-60.6%
168,634
-48.2%
0.00%0.0%
Q3 2018$6,506,000
+39.8%
325,280
+36.3%
0.00%
-33.3%
Q2 2018$4,653,000
+2.0%
238,599
+5.4%
0.00%0.0%
Q1 2018$4,562,000
+137.7%
226,388
+56.3%
0.00%
+200.0%
Q4 2017$1,919,000
-33.9%
144,817
-8.0%
0.00%
-50.0%
Q3 2017$2,905,000
-8.8%
157,438
-9.0%
0.00%0.0%
Q2 2017$3,184,000
+14.0%
173,023
+39.7%
0.00%0.0%
Q1 2017$2,792,000
-39.5%
123,814
-6.6%
0.00%
-33.3%
Q4 2016$4,615,000
+47.8%
132,610
+4.1%
0.00%
+50.0%
Q3 2016$3,122,000
+1.2%
127,396
-1.2%
0.00%0.0%
Q2 2016$3,086,000
+13.8%
129,008
+11.3%
0.00%0.0%
Q1 2016$2,712,000
-22.8%
115,886
-0.5%
0.00%
-33.3%
Q4 2015$3,515,000
-24.3%
116,425
-0.3%
0.00%
-25.0%
Q3 2015$4,641,000
-37.6%
116,815
+8.4%
0.00%
-20.0%
Q2 2015$7,443,000
+51.2%
107,770
+19.7%
0.01%
+66.7%
Q1 2015$4,921,000
+41.0%
90,028
+10.0%
0.00%
+50.0%
Q4 2014$3,489,000
+33.0%
81,858
-0.4%
0.00%0.0%
Q3 2014$2,623,000
+45.3%
82,200
-5.6%
0.00%
+100.0%
Q2 2014$1,805,000
-24.8%
87,100
-29.7%
0.00%
-50.0%
Q1 2014$2,399,000
-20.2%
123,9570.0%0.00%0.0%
Q4 2013$3,008,000
+7.3%
123,957
-5.1%
0.00%0.0%
Q3 2013$2,804,000
-9.5%
130,557
-6.2%
0.00%
-33.3%
Q2 2013$3,098,000139,2560.00%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
HealthInvest Partners AB 520,000$15,699,0007.39%
Palo Alto Investors LP 2,835,792$85,613,0004.76%
Opaleye Management Inc. 150,000$4,529,0001.89%
Engaged Capital LLC 61,425$1,854,0001.15%
IRONWOOD INVESTMENT MANAGEMENT LLC 91,400$2,759,0001.14%
Endurant Capital Management LP 111,180$3,357,0001.12%
AlphaOne Investment Services, LLC 86,817$2,621,0000.94%
ASHFORD CAPITAL MANAGEMENT INC 127,625$3,853,0000.91%
ARDSLEY ADVISORY PARTNERS LP 205,000$6,189,0000.81%
STELLIAM INVESTMENT MANAGEMENT, LP 685,000$20,680,0000.62%
View complete list of AMAG PHARMACEUTICALS INC shareholders